Global Surgical Suture Market is Flourishing: Expected to Reach USD 5.22 Billion in 2027
Published | 20 May 2021
A recent study conducted by the strategic consulting and market research firm BlueWeave Consulting revealed that the global surgical suture market was worth USD 3.24 billion in the year 2020. It is further expected to grow at the CAGR of 7.1% during 2021-2027 (forecast period), reaching USD 5.22 billion by 2027. This can be attributed to the increase in the number of road accidents, rise in expenditure on healthcare, increase in popularity of cosmetic surgeries among different age groups, and development of advanced sutures.
Surgical sutures, also known as stitches, are applied with a needle and a piece of thread connected to it. Surgical sutures are used to heal wounds and close surgical incisions. These sutures cause little or no reaction and provide better passage of the thread via tissue. However, the growing preference for minimally invasive surgical procedures, as well as the availability of alternative wound care products, are posing major market constraints. Furthermore, growing awareness of innovative surgeries, as well as an increase in the elderly population and demand for better healthcare facilities, are expected to provide lucrative opportunities for the surgical sutures market during the forecast period.
An increasing number of surgical procedures driving market growth
According to a report published by WHO in 2016, the average global surgical rate was 4,469 operations per 100,000 people per year. The majority of them were related to traffic accidents and the injuries that resulted from them, which were the leading causes of surgical care. According to the European Commission Factsheet 2017, there are approximately 174 deaths per million populations worldwide per year. Moreover, according to WHO statistics, approximately 1.3 million people die on the roads each year. With every car accident, 20 other people suffer non-fatal injuries that often necessitate surgical intervention.
The elderly population is at a higher risk of chronic diseases and conditions and requires frequent surgeries. Adults aged 65 and above account for a sizable proportion of surgeries performed in the United States. The rapidly rising elderly population, as well as the increasing prevalence of various chronic diseases, are expected to significantly increase the number of surgeries performed globally.
Presence of alternative wound care management products impeding market growth
Topical skin fixative, hemostatic sealing agents, and wound closure devices are some substitutes for surgical sutures. These alternative products reduce the healing time and minimize post-operative care. For instance, stapling is faster and quicker than suturing. Wound closure strips and tapes can be used to close smaller tearing. These products provide better closure in the case of aging patients, especially those with frail skin. Due to their efficiency and benefits over surgical sutures, the presence of alternatives is a major restraint for the market.
Request For Free Sample Report @ https://www.blueweaveconsulting.com/report/surgical-suture-market-report/report-sample
The absorbable suture segment is the largest based on product types
Based on product types, the market has been bifurcated into absorbable and non-absorbable sutures. The absorbable suture segment is anticipated to hold a larger market share in the global surgical suture market during the forecast period. This is due to its ability to provide temporary relief to a wound until it heals. Moreover, it is a cost-effective treatment as it dissolves within the body after a certain period of time.
North America Holds the Largest Market Share
Based on region, the global surgical suture market is categorized into North America, Europe, the Asia-Pacific, Latin America, and the Middle East & Africa. Among all the regions, North America holds the largest market share due to factors such as the proliferation of advanced technology, growing household income, and the presence of major companies in the region. Furthermore, high investments in healthcare R&D in the United States and Canada are expected to propel the market forward during the forecast period.
Impact of COVID-19 Outbreak
The novel coronavirus has had an adverse effect on the global surgical suture market due to the restrictions imposed on the operational hours of general surgical procedures across the globe to prevent the spread of the deadly virus. Furthermore, the closure of several departments in various hospitals around the world due to a lack of manpower impacted the number of surgeries. This has caused people all over the world to postpone surgical procedures. In an event that surgery is needed urgently, surgical teams are required to wait for COVID-19 test results from the admitted patients who are suspected of being infected.
In the event of a staff shortage in the operating theatre, emergency surgical procedures, especially at night, should be contemplated only after a sufficient presence of staff and equipment has been determined. Furthermore, the aerosol generated during procedures such as intubation, blood electrocautery, catheter insertion, and so on, raises the risk of infection in healthcare workers from patients who test positive for COVID-19 or those who are at high risk of infection. Thus, a decrese in general surgical procedures caused by the ongoing pandemic has impacted the global surgical sutures market unfavorably.
Key Market Players: Some of the leading market players in the global surgical suture market are B. Braun Melsungen AG, Boston Scientific Corporation, CP Medical, Demetech Corporation, Johnson & Johnson, Coloplast Corporation, Smith & Nephew Plc, Molnlycke Healthcare, Internacional Farmacéutica S.A. de C.V., Peters Surgical, Medtronic Plc, Surgical Specialties Corporation, W. L. Gore & Associates, Inc., Apollo Endosurgery Inc., Ethicon US, LLC, Integra LifeSciences, Sutures India Pvt. Ltd., and other prominent players. To maintain market dominance, market players are constantly engaging in product launches, alliances, mergers and acquisitions, and collaborations.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of global surgical suture market size & forecast. The report promises to provide recent technology trends of the global surgical suture market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online & offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost up the performance of your business solutions. BWC has built its reputation from the scratches by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt. Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- Global Surgical Suture Market By Product (Absorbable and Non-Absorbable); By Form (Natural and Synthetic); By Material (Monofilament and Multifilament); By Application (Gynaecology, Orthopaedic, Cardiology, Ophthalmic and General Surgery); By Region (North America, Europe, the Asia-Pacific, Latin America and Middle-East & Africa); Trend Analysis, Competitive Market Share & Forecast, 2017-2027
Publish Date: May 2021
The global surgical suture market was worth USD 3.24 billion in the year 2020. It is further projected to reach USD 5.22 billion at a CAGR of 7.1% during the forecast period (2021-2027).
Relevant Press Releases
- Global Fetal Monitoring Market Retains Robust Growth—Projected to Reach worth USD 5.3 Billion in 2027
- India Stent Market Size Growing at Steady CAGR of 4.8% to Reach USD 426.5 Million by 2029
- Global Anti-Snoring Devices Market Size Set to Grow at Significant CAGR of 8.15% Reaching USD 2.48 Billion by 2029
- Global Intraoperative Imaging Market Size More Than Doubles to Touch worth USD 577.5 Million by 2029
- United States Endoscope Reprocessing Market Size Booming to Cross 3.5 Billion by 2029